SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Engy Mohamed El-Ghitany, Moataza M. Abdel Wahab, Ekram W. Abd El-Wahab, Safaa Hassouna, Azza G. Farghaly, A comprehensive hepatitis C virus risk factors meta-analysis (1989–2013); Do they differ in Egypt?, Liver International, 2015, 35,
  2. 2
    Amira Mohsen, Adeline Bernier, Lenaig LeFouler, Elisabeth Delarocque-Astagneau, Mai El-Daly, Sherif El-Kafrawy, Salwa El-Mango, Mohamed Abdel-Hamid, Mohsen Gadallah, Gamal Esmat, Mostafa K. Mohamed, Arnaud Fontanet, Hepatitis C virus acquisition among Egyptians: analysis of a 10-year surveillance of acute hepatitis C, Tropical Medicine & International Health, 2015, 20, 1
  3. 3
    Carolina Simunovic, Michi M. Shinohara, Complications of Decorative Tattoos: Recognition and Management, American Journal of Clinical Dermatology, 2014, 15, 6, 525

    CrossRef

  4. 4
    Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, Nicola Coppola, Guglielmo Borgia, GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infection, Expert Review of Anti-infective Therapy, 2014, 12, 10, 1179

    CrossRef

  5. 5
    Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, Guglielmo Borgia, Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?, Expert Review of Anti-infective Therapy, 2014, 12, 7, 763

    CrossRef

  6. 6
    Ivan Gentile, Nicola Coppola, Antonio Riccardo Buonomo, Emanuela Zappulo, Guglielmo Borgia, Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus, Expert Opinion on Investigational Drugs, 2014, 23, 9, 1211

    CrossRef

  7. 7
    Ivan Gentile, Antonio Riccardo Buonomo, Federico Borgia, Giuseppe Castaldo, Guglielmo Borgia, Ledipasvir: a novel synthetic antiviral for the treatment of HCV infection, Expert Opinion on Investigational Drugs, 2014, 23, 4, 561

    CrossRef

  8. 8
    Ivan Gentile, Antonio Riccardo Buonomo, Federico Borgia, Emanuela Zappulo, Giuseppe Castaldo, Guglielmo Borgia, MK-5172: a second-generation protease inhibitor for the treatment of hepatitis C virus infection, Expert Opinion on Investigational Drugs, 2014, 23, 5, 719

    CrossRef

  9. 9
    Ivan Gentile, Antonio Riccardo Buonomo, Guglielmo Borgia, Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection, Expert Review of Anti-infective Therapy, 2014, 12, 9, 1033

    CrossRef

  10. 10
    Ivan Gentile, Emanuela Zappulo, Antonio Riccardo Buonomo, Guglielmo Borgia, Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus, Expert Review of Anti-infective Therapy, 2014, 12, 7, 775

    CrossRef